Explore new blog stories, register for our June 11 webinar with Bristol Myers Squibb, and take a closer look at the PDAC Validated Solution ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏

Inventia Life Science | The Culture Newsletter

This month, we’re sharing new blog content, an upcoming webinar with Bristol Myers Squibb, and a validated PDAC workflow designed for more reproducible translational research.

Upcoming Webinar | June 11 at 11 AM PT / 2 PM ET: Advancing Tumor Microenvironment Modeling for Better Drug Insights

Join us for an upcoming webinar featuring Bristol Myers Squibb and Inventia Life Science on an advanced 3D PDAC model designed to better capture tumor-stroma interactions and cellular diversity.

The session will explore how this model supports more informative therapeutic response studies in a biologically relevant setting, and how scalable, reproducible tissue modeling approaches can help researchers generate more reliable insights for challenging oncology applications.

Register now →

Inventia Insights: New Stories, Perspectives, & Practical Support

Explore the latest from the Inventia blog, including grant-writing support, AACR takeaways, and a new translational oncology story.

New! Grant Writing Support for Biologically Relevant 3D Cell Culture Research
A practical look at how Inventia can help researchers strengthen grant applications involving biologically relevant 3D cell culture research.
Access the guide →

New! How 3D Models Are Strengthening Drug Repurposing in Ovarian Cancer
See how 3D models are helping support ovarian cancer drug repurposing workflows, including research connected to a therapy now in clinical trials.
Read the story →

New! What AACR 2026 Revealed About the Future of Cancer Research
A closer look at the themes and signals from AACR 2026, and what they may mean for the future of cancer research.
Explore the insights →

Featured Workflow: PDAC Validated Solution

Looking for a more reproducible way to study PDAC in a tumor-stroma context? The PDAC Validated Solution provides a standardized 3D tumor-CAF co-culture workflow on RASTRUM, designed to support translational research applications including therapeutic response studies, stromal biology, and combination treatment screening.

Built around defined model parameters, biological and functional validation, and workflow guidance, this solution helps researchers evaluate efficacy in the presence of tumor-stroma crosstalk and investigate mechanisms of drug resistance without building a PDAC co-culture workflow from scratch.

Explore the PDAC Validated Solution →

Available On Demand: Advanced Human Neuroinflammation Models for Drug Discovery

Our recent webinar with MDC Catapult and bit.bio on advanced human neuroinflammation models is now available on demand. If your team is working in neurobiology or evaluating more informative in vitro drug discovery workflows, this session is available to watch anytime.

Watch the recording →